Sildenafil Citrate | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Sildenafil Citrate
US Patents

PharmaCompass Sponsored Ads

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Sildenafil Citrate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

72 API Suppliers, 20 USDMF, 21 CEP/COS, 5 JDMF, 18 EU WC, 14 KDMF, 30 NDC API, 47 Listed Suppliers, $ API Reference Price

72 API Suppliers
20 USDMF
21 CEP/COS
5 JDMF
18 EU WC
14 KDMF
30 NDC API
47 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

36 Drugs in Development

36 Drugs in Development

INTERMEDIATES

14 Intermediate Suppliers

14 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

551 FDF Dossiers, 101 FDA Orange Book, 181 Europe, 52 Canada, 35 Australia, 43 South Africa, 139 Listed Dossiers

551 FDF Dossiers
101 FDA Orange Book
181 Europe
52 Canada
35 Australia
43 South Africa
139 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FOR SUSPENSION;ORAL - EQ 10MG BASE/ML, TABLET;ORAL - EQ 100MG BASE, TABLET;ORAL - EQ 25MG BASE, TABLET;ORAL - EQ 50MG BASE, TABLET;ORAL - EQ 20MG BASE

FOR SUSPENSION;ORAL - EQ 10MG BASE/ML
TABLET;ORAL - EQ 100MG BASE
TABLET;ORAL - EQ 25MG BASE
TABLET;ORAL - EQ 50MG BASE
TABLET;ORAL - EQ 20MG BASE

RELATED EXCIPIENT COMPANIES

1 Minakem, 3 Rochem International Inc, 4 SPI Pharma, 2 Seqens, 5 DKSH, 2 Pharm-RX Chemical, 4 Faran Shimi Pharmaceutical, 1 Chynops Pharma, 7 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 Pramukh Pharmachem, 1 ACG Worldwide, 5 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 12 BASF, 1 Bioplus Life Sciences, 1 Clariant, 10 Corel Pharma Chem, 5 DFE Pharma, 1 Finar, 8 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 32 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 5 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 25 Roquette, 6 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 2 The Dow Chemical Company, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

54 Fillers, Diluents & Binders, 52 Coating Systems & Additives, 29 Controlled & Modified Release, 20 Lubricants & Glidants, 20 Thickeners and Stabilizers, 18 Disintegrants & Superdisintegrants, 17 Film Formers & Plasticizers, 17 Direct Compression, 15 Granulation, 13 Topical, 12 Parenteral, 11 Taste Masking, 10 Co-Processed Excipients, 7 Solubilizers, 7 Chewable & Orodispersible Aids, 6 API Stability Enhancers, 5 Empty Capsules, 5 Emulsifying Agents, 5 Rheology Modifiers, 4 Vegetarian Capsules, 4 Coloring Agents, 1 Soft Gelatin, 1 Surfactant & Foaming Agents

54 Fillers, Diluents & Binders
52 Coating Systems & Additives
29 Controlled & Modified Release
20 Lubricants & Glidants
20 Thickeners and Stabilizers
18 Disintegrants & Superdisintegrants
17 Film Formers & Plasticizers
17 Direct Compression
15 Granulation
13 Topical
12 Parenteral
11 Taste Masking
10 Co-Processed Excipients
7 Solubilizers
7 Chewable & Orodispersible Aids
6 API Stability Enhancers
5 Empty Capsules
5 Emulsifying Agents
5 Rheology Modifiers
4 Vegetarian Capsules
4 Coloring Agents
1 Soft Gelatin
1 Surfactant & Foaming Agents

DIGITAL CONTENT

224 NEWS #PharmaBuzz

224 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 84 Finished Drug Prices, 25 Annual Reports

3 US Medicaid Prescriptions
84 Finished Drug Prices
25 Annual Reports

MARKET PLACE

58 APIs, 9 FDF Dossiers

58 APIs
9 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 US Patents, 4 US Exclusivities, 30 Health Canada Patents

4 US Patents
4 US Exclusivities
30 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 2 USP, 11 Others

3 EDQM
2 USP
11 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 59 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

4 All

01 4CMP DEV LLC

filter Patent Number Reset all filters

4 All

01 111337979

02 111464778

03 111759468

04 112005062

filter API Patent Reset all filters

4 All

01 4Blank

filter FDF Patent Reset all filters

4 All

01 4Y

filter Expiration Date Reset all filters

4 All

01 42038-12-24

Atman Sildenafil Citrate

Product Main Page

01

CMP DEV LLC

SILDENAFIL CITRATE

BioAsia

Not Confirmed

CMP DEV LLC

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2038-12-24

SILDENAFIL CITRATE

US Patent Number : 11337979

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 214952

Patent Use Code : U-3582

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-12-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

CMP DEV LLC

SILDENAFIL CITRATE

BioAsia

Not Confirmed

CMP DEV LLC

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2038-12-24

SILDENAFIL CITRATE

US Patent Number : 11464778

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 214952

Patent Use Code : U-3582

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-12-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

CMP DEV LLC

SILDENAFIL CITRATE

BioAsia

Not Confirmed

CMP DEV LLC

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2038-12-24

SILDENAFIL CITRATE

US Patent Number : 11759468

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 214952

Patent Use Code : U-3582

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-12-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

CMP DEV LLC

SILDENAFIL CITRATE

BioAsia

Not Confirmed

CMP DEV LLC

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2038-12-24

SILDENAFIL CITRATE

US Patent Number : 12005062

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 214952

Patent Use Code : U-3582

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-12-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!